David W. J. Clark

1.3k total citations
37 papers, 944 citations indexed

About

David W. J. Clark is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health and Physiology. According to data from OpenAlex, David W. J. Clark has authored 37 papers receiving a total of 944 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmacology, 7 papers in Pediatrics, Perinatology and Child Health and 7 papers in Physiology. Recurrent topics in David W. J. Clark's work include Inflammatory mediators and NSAID effects (6 papers), Hormonal Regulation and Hypertension (5 papers) and Pharmacogenetics and Drug Metabolism (4 papers). David W. J. Clark is often cited by papers focused on Inflammatory mediators and NSAID effects (6 papers), Hormonal Regulation and Hypertension (5 papers) and Pharmacogenetics and Drug Metabolism (4 papers). David W. J. Clark collaborates with scholars based in New Zealand, United Kingdom and United States. David W. J. Clark's co-authors include E. L. Phelan, R. Laverty, Johanna Strandell, Mira Harrison‐Woolrych, Simran Maggo, Martin A. Kennedy, Deborah Layton, Saad Shakir, Kenneth M. Taylor and David M Coulter and has published in prestigious journals such as Circulation Research, British Journal of Pharmacology and International Journal of Obesity.

In The Last Decade

David W. J. Clark

36 papers receiving 857 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David W. J. Clark New Zealand 17 199 163 156 145 132 37 944
Scott R. Hamann United States 16 207 1.0× 125 0.8× 140 0.9× 171 1.2× 78 0.6× 37 929
B. Norlander Sweden 23 168 0.8× 281 1.7× 83 0.5× 161 1.1× 82 0.6× 53 1.1k
A. J. J. Wood United States 18 298 1.5× 142 0.9× 132 0.8× 173 1.2× 142 1.1× 35 1.2k
D R Abernethy United States 16 143 0.7× 204 1.3× 104 0.7× 88 0.6× 108 0.8× 31 981
Amitava Chakrabarti India 23 260 1.3× 171 1.0× 199 1.3× 347 2.4× 158 1.2× 79 1.3k
Barry D. Zussman United Kingdom 15 152 0.8× 344 2.1× 138 0.9× 107 0.7× 126 1.0× 20 915
A. Darragh Ireland 19 182 0.9× 199 1.2× 127 0.8× 71 0.5× 64 0.5× 71 1.1k
Marianne Frisk‐Holmberg Sweden 21 215 1.1× 243 1.5× 78 0.5× 141 1.0× 75 0.6× 54 1.3k
Emil R. Smith United States 16 211 1.1× 133 0.8× 129 0.8× 125 0.9× 113 0.9× 45 840
Stuart Harris United States 15 269 1.4× 205 1.3× 72 0.5× 104 0.7× 89 0.7× 27 911

Countries citing papers authored by David W. J. Clark

Since Specialization
Citations

This map shows the geographic impact of David W. J. Clark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David W. J. Clark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David W. J. Clark more than expected).

Fields of papers citing papers by David W. J. Clark

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David W. J. Clark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David W. J. Clark. The network helps show where David W. J. Clark may publish in the future.

Co-authorship network of co-authors of David W. J. Clark

This figure shows the co-authorship network connecting the top 25 collaborators of David W. J. Clark. A scholar is included among the top collaborators of David W. J. Clark based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David W. J. Clark. David W. J. Clark is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mitchell, L., et al.. (2014). 228 Telemedicine videoconferencing – breaking down the barriers for cystic fibrosis (CF) patients living in rural and remote areas. Journal of Cystic Fibrosis. 13. S105–S105. 2 indexed citations
2.
Rakha, Emad A., et al.. (2012). Efficacy of an incident-reporting system in cellular pathology: a practical experience. Journal of Clinical Pathology. 65(7). 643–648. 6 indexed citations
3.
Maggo, Simran, David W. J. Clark, & John C. Ashton. (2011). The effect of statins on performance in the Morris water maze in guinea pig. European Journal of Pharmacology. 674(2-3). 287–293. 8 indexed citations
4.
Maggo, Simran, Martin A. Kennedy, & David W. J. Clark. (2010). Clinical Implications of Pharmacogenetic Variation on the Effects of Statins. Drug Safety. 34(1). 1–19. 51 indexed citations
5.
Harrison‐Woolrych, Mira, et al.. (2006). Bruising associated with sibutramine: results from postmarketing surveillance in New Zealand. International Journal of Obesity. 30(8). 1315–1317. 3 indexed citations
6.
Harrison‐Woolrych, Mira, et al.. (2006). QT interval prolongation associated with sibutramine treatment. British Journal of Clinical Pharmacology. 61(4). 464–469. 31 indexed citations
7.
Clark, David W. J., et al.. (2004). Linking Pharmacovigilance with Pharmacogenetics. Drug Safety. 27(15). 1171–1184. 16 indexed citations
8.
Clark, David W. J. & Mira Harrison‐Woolrych. (2004). Sibutramine may be associated with memory impairment. BMJ. 329(7478). 1316.1–1316.1. 16 indexed citations
9.
Harrison‐Woolrych, Mira & David W. J. Clark. (2004). Nose bleeds associated with use of risperidone. BMJ. 328(7453). 1416.1–1416.1. 14 indexed citations
10.
Coulter, David M, Anneke Passier, David W. J. Clark, & Eugène van Puijenbroek. (2003). Activation of Pain by Sumatriptan. Headache The Journal of Head and Face Pain. 43(9). 994–999. 6 indexed citations
11.
Clark, David W. J., et al.. (2000). Drug metabolism genotypes and their association with adverse drug reactions in selected populations: a pilot study of methodology. Pharmacoepidemiology and Drug Safety. 9(5). 393–400. 6 indexed citations
12.
13.
Morgan, Andrew D. & David W. J. Clark. (1998). CNS Adverse Effects of Nonsteroidal Anti-Inflammatory Drugs. CNS Drugs. 9(4). 281–290. 16 indexed citations
14.
Taylor, D. Robin, David W. J. Clark, Susan Dovey, & Murray Tilyard. (1994). The prescribing and adverse reactions of nonsteroidal antiinflammatory drugs in general practice: a Dunedin study.. PubMed. 107(981). 263–6. 4 indexed citations
15.
Overton, Paul G., et al.. (1992). Amelioration of some neuroleptic-induced deficits by the NMDA antagonist MK-801 in a conditioned reaction time task. Behavioural Pharmacology. 3(1). 57–64. 6 indexed citations
16.
Clark, David W. J. & Karabi Ghose. (1992). Neuropsychiatric Reactions to Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) The New Zealand Experience. Drug Safety. 7(6). 460–465. 13 indexed citations
17.
Knight, James, Angela Campbell, Sheila Williams, & David W. J. Clark. (1991). KNOWLEDGEABLE NON-COMPLIANCE WITH PRESCRIBED DRUGS IN ELDERLY SUBJECTS—A STUDY WITH PARTICULAR REFERENCE TO NON-STEROIDAL ANTIINFLAMMATORY AND ANTIDEPRESSANT DRUGS. Journal of Clinical Pharmacy and Therapeutics. 16(2). 131–137. 9 indexed citations
18.
Clark, David W. J. & I. Ralph Edwards. (1988). Adverse Drug Reaction Reporting and Retrospective Phenotyping for Oxidation Polymorphism. PubMed. 3(3). 241–247. 5 indexed citations
19.
Sinclair, Barbara, David W. J. Clark, & Malcolm R. Sears. (1987). Use of anti-asthma drugs in New Zealand.. Thorax. 42(9). 670–675. 18 indexed citations
20.
Simpson, F. O., et al.. (1973). Studies on the New Zealand Strain of Genetically Hypertensive Rats. Clinical Science. 45(s1). 15s–21s. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Scott R. Hamann Breakdown of academic impact, for papers by B. Norlander Breakdown of academic impact, for papers by A. J. J. Wood Breakdown of academic impact, for papers by D R Abernethy Breakdown of academic impact, for papers by Amitava Chakrabarti Breakdown of academic impact, for papers by Barry D. Zussman Breakdown of academic impact, for papers by A. Darragh Breakdown of academic impact, for papers by Marianne Frisk‐Holmberg Breakdown of academic impact, for papers by Emil R. Smith Breakdown of academic impact, for papers by Stuart Harris
Rankless by CCL
2026